Sc. Rubin et Tc. Randall, Ten-year follow-up of ovarian cancer patients after second-look laparotomywith negative findings, OBSTET GYN, 93(1), 1999, pp. 21-24
Objective: To determine long-term survival and predictors of recurrence in
patients with platinum-treated ovarian cancer who were followed for 10 year
s after second-look laparotomy with negative findings.
Methods: Records were reviewed of 91 consecutive patients with negative fin
dings on second-look laparotomy after platinum-based chemotherapy between J
anuary 1978 and January 1987. Statistical analysis used Kaplan-Meier surviv
al curves, Cox proportional hazards, and multiple logistic regression.
Results: Mean age of patients was 57 (range 30-79) years. Distribution by s
tage and grade was as follows: stage I, ten; II,18; III, 57; IV,six; grade
1, 18; 2, 28; 3, 45. Forty-seven of 91 women had optimal initial cytoreduct
ion. Recurrence-free survival rates for all subjects were 75% at 2 years, 5
5% at 5 years, and 52% at 10 years. For women with stage I disease, the rec
urrence-free survival rate was 90% at 2, 5, and 10 years. For women with st
age II disease, recurrence-free survival rates were 78, 72, and 66% at 2, 5
, and 10 years, respectively. Patients with stage III or nr disease had rec
urrence-free survival rates of 72, 44, and 40% at 2, 5,and 10 years, respec
tively. Risk of recurrent disease was related to tumor stage (relative risk
[RR] 2.02; 95% confidence interval [CI] 1.2 3.3; P = .005), grade (RR 2.00
; 95% CI 1.3, 3.2; P = .004), and presence of a residual tumor of more than
2 cm at the end of initial surgery (RR 3.19; 95% CI 1.2, 8.5; P = .02).
Conclusion: Ovarian cancer patients face an appreciable risk of recurrence
in the first 5 years after second-look laparotomy with negative findings af
ter platinum-based chemotherapy, but those who remain disease free at 5 yea
rs have excellent long-term survival rates. Tumor stage, grade, and presenc
e of a residual tumor of more than 2 cm after initial surgery are significa
nt predictors of recurrence. (C) 1999 by The American College of Obstetrici
ans and Gynecologists.